Biomerieux VITEK 2 AST-N461 test kit recalled for card pouch damage causing false antibiotic resistance results
Some units of the Biomerieux VITEK 2 AST-N461 test kit used to determine antibiotic susceptibility in gram-negative bacteria have damaged card pouches. This damage can cause the test to report false resistant results, which may lead to use of less effective antibiotics or unnecessary antibiotic combinations.
From the FDA notice · Read the official notice ↗ · All bioMérieux recalls
What to do
- Check if your laboratory received units from lot 1333393504 (UDI-DI 03573026637712)
- Do not use affected units for patient testing
- Contact Biomerieux for replacement units or further instructions
- Review any patient results from this lot for accuracy
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811
- Sold in
- Nationwide
- Made for
- All ages (under 100 years)
Details
- Units affected
- 97680 units
- Illnesses reported
- None reported
- Manufactured in
- 595 Anglum Rd, Hazelwood, MO, United States
- Classification
- Class II
- Recall number
- Z-3231-2026
In the FDA's words
- Description
- VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811 The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False resistant results may lead to the use of less effective antibiotic treatments or the association of multiple antibiotics having negative side effects, which could potentially impact patient s health. UDI-DI 03573026637712; Lot Number 1333393504 Distribution: International distribution to the countries of Austria, Germany, Luxembourg. Affected quantity: 97680 units
- Hazard
- The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False resistant results may lead to the use of less effective antibiotic treatments or the association of multiple antibiotics having negative side effects, which could potentially impact patient s health.